Angiotensin II induces tumor necrosis factor-α expression and release from cultured human podocytes

Dedifferentiation of Immortalized Human Podocytes in Response to Transforming Growth Factor- : A Model for Diabetic Podocytopathy

(2011) M. Herman-Edelstein et al.   DIABETES

TNFR2 interposes the proliferative and NF-κB-mediated inflammatory response by podocytes to TNF-α

(2011) Leslie A Bruggeman et al.   LABORATORY INVESTIGATION

The subtypes of peroxisome proliferator-activated receptors expressed by human podocytes and their role in decreasing podocyte injury

(2010) Gianluca Miglio et al.   BRITISH JOURNAL OF PHARMACOLOGY

Angiotensin II revisited: new roles in inflammation, immunology and aging

(2010) Ariela Benigni et al.   EMBO Molecular Medicine

Direct Angiotensin II Type 2 Receptor Stimulation Acts Anti-Inflammatory Through Epoxyeicosatrienoic Acid and Inhibition of Nuclear Factor κB

(2010) Franziska Rompe et al.   HYPERTENSION

The RAAS in the pathogenesis and treatment of diabetic nephropathy

(2010) Piero Ruggenenti et al.   Nature Reviews Nephrology

Epithelial-Mesenchymal Transition as a Potential Explanation for Podocyte Depletion in Diabetic Nephropathy

(2009) Yukinari Yamaguchi et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Podocyte Repopulation Contributes to Regression of Glomerular Injury Induced by Ace Inhibition

(2009) Daniela Macconi et al.   AMERICAN JOURNAL OF PATHOLOGY

Monoclonal antibodies for podocytopathies: rationale and clinical responses

(2009) Maddalena Marasà et al.   Nature Reviews Nephrology

PPARγ stimulation promotes mitochondrial biogenesis and prevents glucose deprivation-induced neuronal cell loss

(2009) Gianluca Miglio et al.   NEUROCHEMISTRY INTERNATIONAL

Renin-angiotensin system revisited

(2008) F. Fyhrquist et al.   JOURNAL OF INTERNAL MEDICINE

Angiotensin II receptor blocker inhibits tumour necrosis factor-alpha-induced cell damage in human renal proximal tubular epithelial cells

(2008) TORU KAGAWA et al.   NEPHROLOGY